TEVA logo

TEVA Net Receivables

Latest reported$3.49B
TEVA Quarterly Net Receivables ($36.00M → $3.49B)
High-resolution chart · PNG

TEVA net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
3,493,000,000
3,393,040,000
3,709,000,000
3,810,000,000
3,564,000,000
3,384,000,000
3,059,000,000
3,462,000,000
3,766,000,000
3,456,000,000
3,408,000,000
3,385,000,000
3,539,000,000
3,435,000,000
3,696,000,000
3,730,000,000
4,471,000,000
4,253,000,000
4,529,000,000
4,046,000,000
4,488,000,000
4,572,000,000
4,581,000,000
4,385,000,000
4,545,000,000
5,189,000,000
5,676,000,000
5,254,000,000
5,260,000,000
5,108,000,000
5,822,000,000
5,665,000,000
6,061,000,000
6,289,000,000
7,128,000,000
7,424,000,000
7,320,000,000
7,264,000,000
7,523,000,000
8,071,000,000
5,374,000,000
5,188,000,000
5,350,000,000
5,275,000,000
5,568,000,000
5,508,000,000
5,408,000,000
5,410,000,000
5,389,000,000
5,275,000,000
5,338,000,000
5,191,000,000
5,305,000,000
5,416,000,000
5,572,000,000
5,782,000,000
5,430,000,000
6,056,000,000
6,213,000,000
5,605,000,000
5,469,000,000
5,576,000,000
5,476,000,000
5,228,000,000
4,985,000,000
5,136,000,000
5,019,000,000
4,689,000,000
4,376,000,000
4,134,000,000
4,653,000,000
3,916,000,000
3,784,000,000
3,600,000,000
3,546,000,000
3,277,000,000
3,051,000,000
2,772,000,000
2,922,000,000
3,698,400,000
3,583,700,000
2,865,400,000
2,180,000,000
1,962,100,000
1,884,300,000
1,987,200,000
1,874,000,000
1,769,100,000
0
1,549,200,000
1,332,400,000
0
1,136,700,000
1,069,400,000
0
864,400,000
866,600,000
797,200,000
817,591,000
787,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.